SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • August 12th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is dated as of _______ __, 2014, between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and the party identified on the signature page hereto (the “Holder”).
AMENDMENT OF WARRANTS May 19, 2014Brainstorm Cell Therapeutics Inc. • August 12th, 2014 • Biological products, (no disgnostic substances)
Reference is hereby made to that certain Subscription Agreement by and between ACCBT Corp., a British Virgin Islands company ("ACCBT"), and Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), dated as of July 2, 2007 (as amended, the "Agreement"), a related Registration Rights Agreement between the Company and ACCBT, any and all issued and outstanding warrants to purchase Company common stock held by ACCBT or its affiliates as of the date hereof (the “ACCBT Warrants”) and any related documents (all of the foregoing documents together as amended to date, the “ACCBT Documents”). Capitalized terms not defined herein shall have the meaning assigned to such terms in the Agreement.
WAIVER REGARDING ANTI-DILUTION May __, 2014Waiver Regarding • August 12th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Reference is hereby made to that certain Warrant issued to [________] ("[WARRANTHOLDER]") by Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), pursuant to the Underwriting Agreement, dated as of August 13, 2013, by and among the Company, Roth Capital Partners, LLC and Maxim Group LLC (the “Warrant”), as set forth on Schedule 1 attached hereto. Capitalized terms not defined herein shall have the meaning assigned to such terms in the Warrant.
WARRANT REDEMPTION AGREEMENTWarrant Redemption Agreement • August 12th, 2014 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This Warrant Redemption Agreement (this “Agreement”) is dated as of May 27, 2014, between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and the party identified on the signature page hereto (the “Holder”).
